Literature DB >> 2410004

CA19-9 as a marker for ovarian cancer: alone and in comparison with CA125.

P A Canney, P M Wilkinson, R D James, M Moore.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2410004      PMCID： PMC1977182          DOI： 10.1038/bjc.1985.161

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  5 in total

1.  Radioimmunometric assay for a monoclonal antibody-defined tumor marker, CA 19-9.

Authors:  B C Del Villano; S Brennan; P Brock; C Bucher; V Liu; M McClure; B Rake; S Space; B Westrick; H Schoemaker; V R Zurawski
Journal:  Clin Chem       Date:  1983-03       Impact factor: 8.327

2.  Carcinoembryonic antigen (CEA) and carbohydrate determinant 19-9 (CA 19-9) localization in 121 primary and metastatic ovarian tumors: an immunohistochemical study with the use of monoclonal antibodies.

Authors:  C Charpin; A K Bhan; V R Zurawski; R E Scully
Journal:  Int J Gynecol Pathol       Date:  1982       Impact factor: 2.762

3.  Immunopathologic characterization of a monoclonal antibody that recognizes common surface antigens of human ovarian tumors of serous, endometrioid, and clear cell types.

Authors:  S E Kabawat; R C Bast; W R Welch; R C Knapp; R B Colvin
Journal:  Am J Clin Pathol       Date:  1983-01       Impact factor: 2.493

4.  A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer.

Authors:  R C Bast; T L Klug; E St John; E Jenison; J M Niloff; H Lazarus; R S Berkowitz; T Leavitt; C T Griffiths; L Parker; V R Zurawski; R C Knapp
Journal:  N Engl J Med       Date:  1983-10-13       Impact factor: 91.245

5.  Ovarian cancer antigen CA125: a prospective clinical assessment of its role as a tumour marker.

Authors:  P A Canney; M Moore; P M Wilkinson; R D James
Journal:  Br J Cancer       Date:  1984-12       Impact factor: 7.640
  5 in total
  8 in total

1.  Label-free detection and molecular profiling of exosomes with a nano-plasmonic sensor.

Authors:  Hyungsoon Im; Huilin Shao; Yong Il Park; Vanessa M Peterson; Cesar M Castro; Ralph Weissleder; Hakho Lee
Journal:  Nat Biotechnol       Date:  2014-04-20       Impact factor: 54.908

2.  Expression of α2,6-sialic acid-containing and Lewis-active glycolipids in several types of human ovarian carcinomas.

Authors:  Kyoko Tanaka; Mikio Mikami; Daisuke Aoki; Kazushige Kiguchi; Isamu Ishiwata; Masao Iwamori
Journal:  Oncol Lett       Date:  2010-09-09       Impact factor: 2.967

3.  Expression of CEA, CA125, CA19-9 and human milk fat globule membrane antigen in ovarian tumours.

Authors:  F Macdonald; R Bird; H Stokes; B Russell; J Crocker
Journal:  J Clin Pathol       Date:  1988-03       Impact factor: 3.411

4.  Serum CA125, CA199 and CEA Combined Detection for Epithelial Ovarian Cancer Diagnosis: A Meta-analysis.

Authors:  Junhong Guo; Jiangtao Yu; Xiaojie Song; Haixia Mi
Journal:  Open Med (Wars)       Date:  2017-05-07

5.  Brain metastasis from ovarian clear cell carcinoma: A case report.

Authors:  Ping Liu; Wei Liu; Yuhua Feng; Xiangyu Xiao; Meizuo Zhong
Journal:  Medicine (Baltimore)       Date:  2019-01       Impact factor: 1.817

6.  Combining Serum DNA Methylation Biomarkers and Protein Tumor Markers Improved Clinical Sensitivity for Early Detection of Colorectal Cancer.

Authors:  Guoying Zhang; Fang He; Guodong Zhao; Zihui Huang; Xiang Li; Xia Xia; Yidi Guo; Weiping Xu; Shangmin Xiong; Yong Ma; Minxue Zheng; Wanli Liu
Journal:  Int J Genomics       Date:  2021-04-21       Impact factor: 2.326

7.  Multivariate logistic regression analysis of the correlation between five biomarkers and ovarian cancer in patients with intermediate-risk: A prospective cross-sectional study.

Authors:  Zhen Liu; Jingjing Wu; Xiuli Wang; Xiaoyang Ji
Journal:  Front Cell Dev Biol       Date:  2022-08-31

8.  Characterization of OM-B monoclonal antibody-defined antigen associated with mucinous type human ovarian tumor.

Authors:  K Nishida; R Ueda; K Sakakibara; Y Minoura; M Ohta; Y Ariyoshi; T Takahashi
Journal:  Jpn J Cancer Res       Date:  1993-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.